Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Craniomaxillofac Surg. 2007 Mar;35(2):126-31. Epub 2007 Apr 20.

Head and neck cancer, treatment, evolution and post therapeutic survival - Part 2: a decade's results 1993-2002.

Author information

  • 1Department of Oral and Maxillofacial Surgery, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.

Abstract

INTRODUCTION AND OBJECTIVES:

In the second part of an analysis of a 10-year period of treating oral cancer patients, the focus was the efficiency of treatment, recurrence rates and survival.

PATIENTS AND METHODS:

From 1485 patients with oral and maxillofacial malignant tumours, 1072 cases could be evaluated. The following data were analyzed statistically: patients' charts and medical records including the follow-up reports.

RESULTS:

From all patients studied, 811 underwent surgical treatment alone, the mean recurrence rate was 23%. The recurrence rate after surgery plus radiotherapy was 38%; after surgical treatment alone it was 23%; the survival rate at 3 and 5 years post-therapeutically was 49% and 31%, respectively.

CONCLUSIONS:

The first choice therapy for carcinomas is surgical. The recurrence rate increased with lymph node involvement and tumour size.

PMID:
17449258
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk